InMed Announces Results of 2025 Annual General and Special Meeting
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug
Silver’s strong performance in 2025 is drawing attention to silver-mining companies. During Q3, the silver price closed in on all-time highs, reaching a
After a year marked by policy changes and trade uncertainty, experts are calling for cleantech investment to be dominated by artificial intelligence
Uranium prices stayed fairly steady in 2025, but experts agree its long-term outlook is compelling, Demand picked up from reactor restarts, new
IRIS Metals Limited (ASX: IR1, “IRIS” or “the Company”) is pleased to announce it has executed a binding Heads of Agreement (HOA)
Gareth Soloway of VerifiedInvesting.com shares his outlook for gold, silver and Bitcoin. For gold, he outlines two different scenarios — a breakout
Skyharbour Resources Ltd. (TSX-V: SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (‘Skyharbour’ or the ‘Company’) is pleased to announce that it
LaFleur Minerals Inc. (CSE: LFLR,OTC:LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’ or ‘Issuer’) announces it has amended its previously disclosed non-brokered
The silver price reached heights not seen in more than 40 years in 2025, posting new all-time highs in the fourth quarter
2025 was a watershed year for gold, which set new highs as its safe-haven appeal increased. As global uncertainty intensified, the metal